Funder
Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Palacio A, Hernández C, Marqués A, Prats J, Espinosa FJ (2004) Long-term study to assess the efficacy of tamsulosin in the control of symptoms and complications developed in patients with symptomatic benign prostatic hyperplasia (OMNICONTROL study): first-year follow-up report. Arch Esp Urol 57(4):451–460 PMID: 15270291
2. Höfner K, Ulrich S, Berges R (2017) [Combined treatment of BPS with tamsulosin and finasteride: literature review and prescription data]. Urol Ausg A 56(5):645–653. https://doi.org/10.1007/s00120-016-0296-x
3. Franco-Salinas G, de la Rosette JJMCH, Michel MC (2010) Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations. Clin Pharmacokinet 49(3):177–188. https://doi.org/10.2165/11317580-000000000-00000
4. Wilde MI, McTavish D, Tamsulosin (1996) Drugs 52(6):883–898. https://doi.org/10.2165/00003495-199652060-00012
5. Dunn CJ, Matheson A, Faulds DM, Tamsulosin (2002) Drugs Aging 19(2):135–161. https://doi.org/10.2165/00002512-200219020-00004